AGITG 2013* ATTAX3: A randomised phase II study evaluating weekly docetaxel,cisplatin, fluoropyrimidine (wTCF) plus or minus panitumumab inadvanced oesophago-gastric cancer. (10528)
10:00 AM
INTEGRATE - A randomised phase II double-blind placebo-controlled study of regorafenib in refractory Advanced Oesophago-Gastric Cancer (AOGC) (10531)
10:00 AM
Phase II trial of gemcitabine, cisplatin and panitumumab in biliary tract cancer (10532)
10:00 AM